Stora Enso Acquires Swedish Cellulose Technology Company
HELSINKI, Oct. 29, 2018 /PRNewswire/ -- STORA ENSO OYJ INVESTOR NEWS 29 October 2018 at 9.00 EET
Stora Enso has increased its ownership up to 100% in the Sweden-based company Cellutech AB. The company specialises in the development of new materials and applications based on cellulose, micro-fibrillated cellulose (MFC) and other wood-based components.
The acquisition of Cellutech supports Stora Enso's vision of replacing fossil-based materials with renewable ones originating from wood. The acquired company works, among others, in the areas of foams for packaging and hydroponics where the markets are continuously growing. Cellulosic foams can, for example, be used in packaging to replace polystyrenes which are the most widely used plastics.
"The acquisition of Cellutech will add a new dimension to our fibre and cellulose capabilities particularly in lightweight cellulose foams and spheres. We are investing in technologies and expertise that will further broaden application development competence in Stora Enso's Biomaterials Division," says Markus Mannström, EVP, Stora Enso Biomaterials.
Established in 2013, Cellutech is an agile team of eight scientists and researchers serving as a link between academia and industry. Cellutech was formed to take world class scientific research developed at SweTree Technologies and Wallenberg Wood Science Center and develop the ideas into commercially successful technologies and products.
The transaction will not have a material financial impact on the Group.
Part of the bioeconomy, Stora Enso is a leading global provider of renewable solutions in packaging, biomaterials, wooden constructions and paper. We believe that everything that is made from fossil-based materials today can be made from a tree tomorrow. Stora Enso has some 26 000 employees in over 30 countries. Our sales in 2017 were EUR 10 billion. Stora Enso shares are listed on Nasdaq Helsinki (Nasdaq Helsinki: STEAV), (Nasdaq Helsinki: STERV) and Nasdaq Stockholm (Nasdaq Stockholm: STE A),(Nasdaq Stockholm: STE R). In addition, the shares are traded in the USA as ADRs (SEOAY). storaenso.com
For further information, please contact:
Ulrika Lilja
EVP, Communications
Tel: +46-72-221-9228
Investor enquiries:
Ulla Paajanen
SVP, Investor Relations
Tel. +358-40-763-8767
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
http://news.cision.com/stora-enso-oyj/i/biomaterials-lab,c2517013 |
Biomaterials lab |
Share this article